MiR-21, a well-known pro-tumor miRNA, directly inhibits PTEN expression, thereby activating the PI3K/AKT pathway and promoting tumor cell proliferation, migration, and survival (Wang et al., 2020). The gene discussed is PIK3CB; the disease is neoplasm.